Brugia malayi soluble and excretory-secretory proteins attenuate development of streptozotocin-induced type 1 diabetes in mice

Agriculture & Biology

• insulin-dependent diabetes mellitus 95%
• excretory-secretory products 93%
• Brugia malayi 93%
• streptozotocin 87%
• mice 37%
• islets of Langerhans 26%
• therapeutics 16%
• autoimmune diseases 15%
• interleukin-10 13%
• splenocytes 11%
• diabetes 11%
• blood glucose 11%
• disease severity 11%
• proteins 11%
• pancreas 11%
• fasting 10%
• immune system 10%
• cytokines 10%
• insulin 9%
• antigens 8%
• pretreatment 8%
• parasites 7%
• antibodies 7%
• pathogens 6%

Medicine & Life Sciences

• Brugia malayi 100%
• Streptozocin 65%
• Type 1 Diabetes Mellitus 58%
• Proteins 24%
• Islets of Langerhans 21%
• Insulin Antibodies 15%
• Interleukin-10 9%
• Autoimmune Diseases 9%
• Pancreas 9%
• Anti-Idiotypic Antibodies 9%
• Blood Glucose 9%
• Parasites 9%
• Therapeutic Uses 9%
• Fasting 8%
• Immune System 8%
• Immunoglobulin G 8%
• Antigens 6%
• Cytokines 6%
• Therapeutics 5%